Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AMAG Pharmaceuticals, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Participants who completed participation in study AMAG-FER-IDA-301 \[NCT01114139\]
2. Female participants of childbearing potential who are sexually active must be on an effective method of birth control and agree to remain on birth control until completion of participation in the study
You may not be if
1. Experienced a serious adverse event (SAE) related to ferumoxytol in study AMAG-FER-IDA-301
2. Female participants who are pregnant, intend to become pregnant, are breastfeeding, or have a positive serum/urine pregnancy test
Clareo Health | A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia
